Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells

Colorectal carcinoma (CRC) is one of the most common types of malignancy worldwide. Recently, neoadjuvant chemotherapy has become an important treatment strategy for CRC. However, treatment frequently fails due to the development of chemoresistance, which is a major obstacle for positive prognosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Tongfa, Jin, Huicheng, Ying, Rongchao, Xie, Qi, Zhou, Chunhua, Gao, Daquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547960/
https://www.ncbi.nlm.nih.gov/pubmed/28713930
http://dx.doi.org/10.3892/mmr.2017.6986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547960/
https://www.ncbi.nlm.nih.gov/pubmed/28713930
http://dx.doi.org/10.3892/mmr.2017.6986

Ejemplares similares